1.
Direct oral anticoagulants (DOACs) in the onco-hematologic patients. Mediterr J Hematol Infect Dis [Internet]. 2025 Feb. 27 [cited 2026 Apr. 21];17(1):e2025022. Available from: https://www.mjhid.org/mjhid/article/view/5897